{"title":"Key Points for Issue.","authors":"","doi":"10.1212/01.cont.0001278628.99653.47","DOIUrl":"https://doi.org/10.1212/01.cont.0001278628.99653.47","url":null,"abstract":"","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1cont00012786289965347"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Spinal Muscular Atrophy.","authors":"Bo Hoon Lee, Emma Ciafaloni","doi":"10.1212/cont.0000000000001750","DOIUrl":"https://doi.org/10.1212/cont.0000000000001750","url":null,"abstract":"<p><strong>Objective: </strong>This article reviews the history, epidemiology, genetics, clinical presentation, multidisciplinary management, and established and emerging therapies for patients with spinal muscular atrophy.</p><p><strong>Latest developments: </strong>Advances in effective disease-modifying therapies and the successful expansion of newborn screening have dramatically altered the natural history of and management approach to spinal muscular atrophy. Reports of prenatal therapy have been published, and earlier therapeutic windows and biomarker research are being explored. Cognitive delays are increasingly recognized in a subset of patients with spinal muscular atrophy.</p><p><strong>Essential points: </strong>The recent availability of treatment options and earlier diagnosis through newborn screening have altered the natural history of spinal muscular atrophy. However, there remains no cure. Despite earlier treatment, the time of vulnerability starts early, particularly for those with two or fewer copies of the <i>SMN2</i> \"back-up\" gene, and some children still demonstrate profound motor delays.</p>","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1545-1563"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Amyotrophic Lateral Sclerosis.","authors":"Mark B Bromberg","doi":"10.1212/cont.0000000000001753","DOIUrl":"https://doi.org/10.1212/cont.0000000000001753","url":null,"abstract":"<p><strong>Objective: </strong>This article describes the nerve loss underlying amyotrophic lateral sclerosis, its clinical manifestations, examination findings leading to the diagnosis, the expanding role of genetics, and available treatment and patient management.</p><p><strong>Latest developments: </strong>The cause of neuron death in patients with amyotrophic lateral sclerosis is not known, but many genes are strongly linked to the disease, in both patients with a family history and those with no history. A multistep pathologic process helps to explain the onset of symptoms later in life, even in patients with associated genes. Posttranslational and epigenetic changes are also important factors. Current clinical trials are based on putative pathologic mechanisms, and some newer therapies are gene-based.</p><p><strong>Essential points: </strong>Amyotrophic lateral sclerosis has distinctive features and can be diagnosed largely from the history and examination, and true mimics are rare. While the cause of neuronal death is not known, pathogenic and risk factor gene variations are present in a number of patients, and posttranscriptional and epigenetic changes are likely major causative factors. Environmental factors likely contribute, but specific avoidable factors have not been identified. Drugs to slow the progress of the disease are currently limited, but trials for all patients with amyotrophic lateral sclerosis continue, including a focus on genetic factors. Patient management is optimized in multidisciplinary amyotrophic lateral sclerosis clinics, and interventions for nutrition with gastric feeding tubes and respiratory insufficiency by noninvasive ventilation enhance patient comfort.</p>","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1529-1544"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Guillain-Barré Syndrome.","authors":"Mamatha Pasnoor","doi":"10.1212/cont.0000000000001764","DOIUrl":"https://doi.org/10.1212/cont.0000000000001764","url":null,"abstract":"<p><strong>Objective: </strong>This article reviews the epidemiology, clinical symptoms, examination findings, pathogenesis, diagnostic criteria, and recent guidelines of Guillain-Barré syndrome (GBS) and its variants, including information on outcome measures, management, and ongoing research.</p><p><strong>Latest developments: </strong>CSF examination and electrodiagnostic testing are useful in some cases to support the diagnosis, particularly when GBS variants are suspected. Antibody testing is of limited value in typical sensorimotor GBS, but useful when GBS variants and nodopathies are considered. According to evidence-based guidelines for the diagnosis and treatment of GBS developed by the European Academy of Neurology and Peripheral Nerve Society, IV immunoglobulin (IVIg) or plasma exchange are the recommended treatment options. The guidelines recommend against using a second IVIg course, or corticosteroids or plasma exchange followed immediately by IVIg. For treatment of pain, gabapentinoids, tricyclic antidepressants, or carbamazepine have been recommended. The Modified Erasmus GBS outcome score and Modified Erasmus GBS Respiratory Insufficiency Score have been recommended. Research is ongoing to find new treatment options.</p><p><strong>Essential points: </strong>GBS is a life-threatening neuromuscular emergency seen frequently worldwide. Symptom progression for less than 4 weeks and findings of sensorimotor deficits and areflexia are required to make the diagnosis. Some patients may present with pain, cranial nerve involvement, autonomic dysfunction, or respiratory insufficiency. If progression continues after 8 weeks from onset, consider the diagnosis of acute-onset chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), which is seen in 5% of patients initially diagnosed with GBS. Approximately 20% of patients have significant residual deficits and poor prognosis despite receiving available treatments.</p>","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1392-1415"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Wellness and Career Sustainability in Neurology.","authors":"Jeffrey Dewey, Jennifer Bickel","doi":"10.1212/cont.0000000000001751","DOIUrl":"https://doi.org/10.1212/cont.0000000000001751","url":null,"abstract":"<p><p>This article reviews drivers of well-being in neurology, using the practice of neuromuscular neurology as an example and high-yield interventions to enhance professional fulfillment. Neurologist burnout, once viewed as a consequence of insufficient personal resilience and poor stress coping strategies, is now recognized as an occupational syndrome resulting from a mismatch between demands and resources. Expert consensus now recognizes that even highly resilient physicians can experience low professional well-being when faced with long-term exposure to human suffering and death, which are common in both neuromuscular practice and neurology in general. Despite rising awareness of this issue in health care workers and the general public, research demonstrates persistently high rates of burnout and related indicators of low well-being among neurologists. Professional fulfillment is the opposite of burnout on the spectrum of neurologist well-being. Although wide-reaching systemic change is necessary to address high-level extrinsic drivers, every neurologist can learn to recognize when they or a colleague is struggling with the demands of practice and respond with evidence-based interventions.</p>","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1564-1576"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diabetic Neuropathies.","authors":"Vera Fridman","doi":"10.1212/cont.0000000000001744","DOIUrl":"10.1212/cont.0000000000001744","url":null,"abstract":"<p><strong>Objective: </strong>This article provides an update on the biological mechanisms and risk factors for the varied manifestations of diabetes-associated nerve injury, and reviews current diagnostic and treatment approaches.</p><p><strong>Latest developments: </strong>Diabetic peripheral neuropathy was recently identified as one of the top five leading global neurologic causes of disease burden. Multiple metabolic derangements beyond hyperglycemia, such as the metabolic syndrome, drive diabetic peripheral neuropathy pathogenesis. Social determinants of health are also increasingly seen as important contributors. The biological effects of diabetes are detrimental to both peripheral nerve axons and Schwann cells, and disruptions to the intricate Schwann cell-axon relationship in the diabetic environment are becoming better understood. With improved technology and larger data sets, genetic and epigenetic contributors to diabetic peripheral neuropathy and neuropathic pain are also emerging.</p><p><strong>Essential points: </strong>Diabetes-associated nerve injury is highly prevalent and results in a marked reduction in quality of life and increased mortality. Despite this disease burden, screening for its many manifestations remains insufficient. Disease-modifying treatments are also limited, necessitating the early implementation of preventative measures. To reduce nerve injury burden in people with diabetes, clinicians must work in multidisciplinary teams and tailor treatments to the patient's symptoms and risk factors.</p>","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1317-1339"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SELF-ASSESSMENT AND CME.","authors":"","doi":"10.1212/cont.0000000000001759","DOIUrl":"https://doi.org/10.1212/cont.0000000000001759","url":null,"abstract":"","PeriodicalId":52475,"journal":{"name":"CONTINUUM Lifelong Learning in Neurology","volume":"32 5","pages":"1577"},"PeriodicalIF":0.0,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149118573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}